Literature DB >> 17700524

ATM-dependent nuclear accumulation of IKK-alpha plays an important role in the regulation of p73-mediated apoptosis in response to cisplatin.

K Yoshida1, T Ozaki, K Furuya, M Nakanishi, H Kikuchi, H Yamamoto, S Ono, T Koda, K Omura, A Nakagawara.   

Abstract

I kappa B kinase (IKK) complex plays an important role in the regulation of signaling pathway that activates nuclear factor-kappa-B (NF-kappaB). Recently, we reported that cisplatin (CDDP) treatment causes a remarkable nuclear accumulation of IKK-alpha in association with stabilization and activation of p73. However, underlying mechanisms of CDDP-induced nuclear accumulation of IKK-alpha are elusive. Here, we found that ataxia-telangiectasia mutated (ATM) is one of upstream mediators of IKK-alpha during CDDP-induced apoptosis. In response to CDDP, ATM was phosphorylated at Ser-1981, which was accompanied with nuclear accumulation of IKK-alpha in HepG2 cells, whereas CDDP treatment had undetectable effects on IKK-alpha in ATM-deficient cells. Indirect immunofluorescence experiments demonstrated that phosphorylated form of ATM colocalizes with nuclear IKK-alpha in response to CDDP. In vitro kinase assay indicated that ATM phosphorylates IKK-alpha at Ser-473. Moreover, IKK-alpha-deficient MEFs displayed CDDP-resistant phenotype as compared with wild-type MEFs. Taken together, our present results suggest that ATM-mediated phosphorylation of nuclear IKK-alpha, which stabilizes p73, is one of the main apoptotic pathways in response to CDDP.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17700524     DOI: 10.1038/sj.onc.1210722

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  27 in total

1.  RUNX3 modulates DNA damage-mediated phosphorylation of tumor suppressor p53 at Ser-15 and acts as a co-activator for p53.

Authors:  Chizu Yamada; Toshinori Ozaki; Kiyohiro Ando; Yusuke Suenaga; Ken-ichi Inoue; Yoshiaki Ito; Rintaro Okoshi; Hajime Kageyama; Hideki Kimura; Masaru Miyazaki; Akira Nakagawara
Journal:  J Biol Chem       Date:  2010-03-30       Impact factor: 5.157

Review 2.  Therapeutic prospects for p73 and p63: rising from the shadow of p53.

Authors:  Anna Vilgelm; Wael El-Rifai; Alexander Zaika
Journal:  Drug Resist Updat       Date:  2008-09-17       Impact factor: 18.500

3.  AMPK couples p73 with p53 in cell fate decision.

Authors:  Y Adamovich; J Adler; V Meltser; N Reuven; Y Shaul
Journal:  Cell Death Differ       Date:  2014-05-30       Impact factor: 15.828

4.  A Whole-genome CRISPR Screen Identifies a Role of MSH2 in Cisplatin-mediated Cell Death in Muscle-invasive Bladder Cancer.

Authors:  Andrew Goodspeed; Annie Jean; James C Costello
Journal:  Eur Urol       Date:  2018-11-07       Impact factor: 20.096

Review 5.  Live cell imaging and systems biology.

Authors:  Myong-Hee Sung; James G McNally
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2010-08-20

Review 6.  The intersection between DNA damage response and cell death pathways.

Authors:  S Nowsheen; E S Yang
Journal:  Exp Oncol       Date:  2012-10

7.  Deregulation of IKBKE is associated with tumor progression, poor prognosis, and cisplatin resistance in ovarian cancer.

Authors:  Jian-Ping Guo; Shao-Kun Shu; Lili He; Yi-Chun Lee; Patricia A Kruk; Seija Grenman; Santo V Nicosia; Gil Mor; Michael J Schell; Domenico Coppola; Jin Q Cheng
Journal:  Am J Pathol       Date:  2009-06-04       Impact factor: 4.307

8.  Phospho-ΔNp63α/microRNA feedback regulation in squamous carcinoma cells upon cisplatin exposure.

Authors:  Yiping Huang; Dafna Kesselman; Darya Kizub; Rafael Guerrero-Preston; Edward A Ratovitski
Journal:  Cell Cycle       Date:  2013-01-23       Impact factor: 4.534

9.  A proposed bailout for A-T patients?

Authors:  Richard A Gatti; Susan Perlman
Journal:  Eur J Neurol       Date:  2009-06       Impact factor: 6.089

10.  The mRNA-stabilizing factor HuR protein is targeted by β-TrCP protein for degradation in response to glycolysis inhibition.

Authors:  Po-Chen Chu; Hsiao-Ching Chuang; Samuel K Kulp; Ching-Shih Chen
Journal:  J Biol Chem       Date:  2012-10-31       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.